We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 16 OCTOBER 2009
Conditions Imposed on Pfizer & GM Deals as Chinese Merger Control Ramps Up

Mayer Brown
Contributor

Mayer Brown
Mayer Brown is a leading international law firm positioned to represent the world’s major...
View firm profileChina's Ministry of Commerce (MOFCOM) has announced two new conditional clearance decisions under the country's Anti-Monopoly Law (AML) merger control system, meaning five deals have now been subject to conditional approval or outright prohibition since the law commenced.
ChinaAntitrust/Competition Law





